Health News Headlines - Yahoo News
Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on
top health stories.
Why Superpotent Synthetic Opioids Are 'Crazy Dangerous,' DEA Says
27 Sep 2016 at 9:15am
As the opioid epidemic has continued to grow in multiple parts of the country, extremely potent synthetic forms of the painkillers ? especially fentanyl and carfentanil ? have become more common among everyday users, according to U.S. authorities. Last week, the Drug Enforcement Agency (DEA) issued a public warning to law enforcement about the safety risks of taking or interacting with synthetic opioids, especially carfentanil and fentanyl. "Carfentanil is surfacing in more and more communities," DEA Acting Administrator Chuck Rosenberg said in a statement on Friday.
Appeals court blocks Pennsylvania hospital merger
27 Sep 2016 at 8:53am
Reversing a lower court ruling, the 3rd U.S. Circuit Court of Appeals in Philadelphia ordered a preliminary injunction against the combination of Penn State Hershey Medical Center and PinnacleHealth System. By a 3-0 vote, the appeals court said the U.S. Federal Trade Commission and the Commonwealth of Pennsylvania would likely be able to show that the merger would harm competition, and could boost prices for patients.
Engineered blood vessels grow in lambs
27 Sep 2016 at 8:36am
In a hopeful development for children born with congenital heart defects, scientists said Tuesday they had built artificial blood vessels which grew unaided when implanted into lambs, right into adulthood. If repeated in humans, such grafts would spare afflicted children the need for repeated surgeries, an expert team from the University of Minnesota reported in the journal Nature Communications. "This might be the first time we have an 'off-the-shelf' material that doctors can implant in a patient, and it can grow in the body," study co-author Robert Tranquillo said in a statement.
Many Haiti orphanages run by child traffickers, says J.K. Rowling's charity
27 Sep 2016 at 8:24am
By Lin Taylor LONDON (Thomson Reuters Foundation) - Four in five children living in Haiti's orphanages have at least one living parent and are sold or given to the homes on false promises of an education or medical care, according to a charity founded by British author J.K. Rowling. London-based charity Lumos said many orphanages in the poor Caribbean nation were run by enterprising traffickers who starved and beat children to attract sympathy and money from well-intentioned donors. "When people hear the word 'orphanage', they imagine that it's a good thing or they imagine that it's necessary," Lumos Chief Executive Georgette Mulheir told the Thomson Reuters Foundation on Tuesday.
Music therapy may help kids cope with immunization shots
27 Sep 2016 at 8:21am
By Linda Thrasybule (Reuters Health) - When little kids need to get a painful injection, music therapy can help them get through the procedure, a new study suggests. Children who received music therapy during a routine immunization visit were less stressed and better able to cope with the procedure than those who didn?t receive music therapy, and their parents were less stressed, too, the study found. ?Although it certainly won?t eliminate a child?s pain or distress, using music to distract them could help them focus less on the pain, which can improve their perception of getting shots,? said Olivia Yinger, the study?s author and a music therapist from the University of Kentucky in Lexington.
Feds charge seller of mislabeled Chinese 'Viagra substitute'
27 Sep 2016 at 8:14am
ATLANTA (AP) ? Federal prosecutors say an Alabama man who imported a Chinese drug sold as a Viagra substitute has been charged with intentionally defrauding and misleading consumers. They say the drug sold as Zhen Gong Fu fails to list a potentially dangerous ingredient on its label.
Amgen's multiple myeloma drug falls short in new-patient study
27 Sep 2016 at 8:06am
Amgen Inc said on Tuesday its multiple myeloma drug, Kyprolis, did not fare better than Takeda Pharmaceutical Co Ltd's older therapy Velcade in a study involving patients who had not yet been treated for the disease. The U.S. Food and Drug Administration has already approved Kyprolis for patients with relapsed or refractory multiple myeloma who have previously undergone treatment. Patients treated with Kyprolis did not show a statistically significant improvement in slowing the cancer's progression compared with those given Velcade in the late-stage study.
Unhappy Target customers send strong message on pill bottles
27 Sep 2016 at 8:00am
Longtime customers of Target's pharmacies are finding a change in pill bottle design hard to swallow. After CVS began operating Target's drugstores earlier this year, distraught customers have been asking ...
WHO, Red Cross say urgent to evacuate wounded from east Aleppo
27 Sep 2016 at 7:58am
By Stephanie Nebehay GENEVA (Reuters) - The World Health Organization (WHO) and Red Cross called on Tuesday for dozens of sick and wounded people in the embattled eastern part of the Syrian city of Aleppo to be evacuated through safe corridors for treatment. The Syrian military, helped by Iranian-backed Shi'ite militias and the Russian air force, launched a campaign to take rebel-held eastern Aleppo last week, where the WHO said only 35 doctors remained to care for more than 250,000 people. Syrian pro-government forces attacked the opposition-held sector of Aleppo on several fronts on Tuesday, the biggest ground assault yet in a campaign that has destroyed a U.S.-backed ceasefire.
Kyrgyz president has recovered, may leave hospital this week: office
27 Sep 2016 at 7:35am
Kyrgyz President Almazbek Atambayev's condition has improved and he may be discharged from hospital by the end of the week, his office said on Tuesday, a week after the 60-year-old leader went on medical leave due to suspected heart problems. Atambayev is being treated in Moscow after suffering chest pains on a flight last week and undergoing an examination in Turkey.
Asia's poor choking on filthy air
27 Sep 2016 at 6:46am
Polluted air is a "public health emergency", the World Health Organization said Tuesday, adding nine out of 10 people globally breathe bad air that is blamed for more than six million deaths a year. Southeast Asia and the Western Pacific region -- including China -- are the hardest hit, the data showed. South Asia is also badly affected, with the WHO saying poor air quality is responsible for the deaths of more than 600,000 people in India and 37,000 people in Bangladesh every year.
Halting school meals in Mali could keep thousands of children out of class: U.N
27 Sep 2016 at 5:50am
By Kieran Guilbert DAKAR (Thomson Reuters Foundation) - Taking away school meals from 180,000 pupils going back to class in Mali, where insecurity has closed schools in the north, may deprive even more children of an education, the U.N. World Food Programme (WFP) said on Tuesday. Halting a school meals programme due to a lack of funding will leave these children, in around 1,000 schools across Mali, without a guaranteed healthy meal each day, the WFP said.
Beware the air we breathe
27 Sep 2016 at 5:31am
Health-damaging atmospheric pollutants, which the World Health Organization warned Tuesday affected nine out of every 10 people, originate mainly from industry, heating and transport. Chronic exposure has been linked not only to respiratory ailments, but also cancers, heart disease and stroke.
Bristol-Myers to test Opdivo with Nektar drug for several cancers
27 Sep 2016 at 4:44am
(Reuters) - Bristol-Myers Squibb Co said on Tuesday it would evaluate the use of its blockbuster cancer immunotherapy Opdivo in combination with an experimental drug from Nektar Therapeutics to treat multiple cancers. The collaboration involves Nektar's NKTR-214, an experimental immuno-stimulatory therapy designed to increase the expression of PD-1 on immune cells. The trials will evaluate the potential for the combination to improve on the current standard-of-care to treat melanoma and cancers of the kidney, colorectal system, bladder and the most common form of lung cancer.
Paris climate targets to cost Asia $300 billion a year, but will help save li...
27 Sep 2016 at 4:42am
By Beh Lih Yi JAKARTA (Thomson Reuters Foundation) - Developing economies in Asia will have to spend $300 billion a year until 2050 to meet targets set by the Paris climate deal, but can expect to save thousands of lives and avoid worsening poverty if they shift to low-carbon growth, research showed on Tuesday. The Asian Development Bank (ADB) said the economic returns of spending on the Paris climate targets far outweighed the costs in the developing region - one of the most vulnerable to climate change and disasters like typhoons and flooding. The Manila-based bank's definition of developing Asia comprises 45 of the ADB's member countries in Asia Pacific including Cambodia, Indonesia, the Philippines and Vietnam.